Lamed

Lamed is a Germany-based medical device company focused on vascular and cardiovascular products and commercial market access. The company has operated as a distributor and access platform serving hospitals and group purchasing organization networks in Germany, with a portfolio spanning vascular surgery, endovascular procedures, and related interventional specialties. Publicly available descriptions indicate that Lamed has offered products such as occlusion and irrigation catheters and embolectomy catheters, and has also been associated with vascular and cardiac surgery as well as stent graft-related products. In June 2023, Lamed was acquired by Translumina as part of Translumina's strategy to expand its cardiovascular footprint in Germany and Europe. Following the acquisition, Lamed appears to remain an operating business within the broader Translumina group rather than a standalone independent company.